Dr. Emanuel Krobath

Downstream process development expert supporting customers with crucial knowledge and hands on expertise to reach their goals from bench scale to manufacturing scale.

Providing upscale-able solutions and process development for biopharma downstream processes such as gene therapy, mAbs, rProts and vaccines through small scale trials and consulting in Austria, Central Eastern Europe, Israel and South Africa. Target customers include pre-clinical- and clinical phase-one customers.

Responsible for the distribution of Pall Laboratory products in cooperation with VWR in Austria, Slovenia, Croatia, Greece, Cyprus, Slovakia and the Ukraine. Responsible for product training of distributor sales rep and establishing of customer relation between VWR and PALL Life Science, including the help and support of VWR and their customers with in depth knowledge of our filtering solutions

Travel through South East Asia, Australia and New Zealand

Set up of a rapid detection method for the methicillin resistant s. aureus using the antibody microarray technology.

Identification of three MRSA specific biomarkers followed by recombinant expression, purification and characterization using ELISA, SDS-PAGE, HPLC-Sec.

Affinity maturation of a cancer immunotherapeutic antibody fragment by the application of error prone PCR and chain shuffling followed by yeast display and FACS.

Peanut allergen desensitization using BALB/c mouse model and CHO cell culture.

Interpretation the p53 signaling pathway in cancer while using different inhibitor substances in cell culture.

Comparison of different DNA isolation methods and kits for wheat samples.

molecular medicine, molecular immunology and genetics, antibody/protein engineering, MRSA;

Antibody Engineering, Tumor Biology, Tumor Therapy, Immunollogy, Microbiology, Molecular Biology